The biggest question we have whenever we visit one of these toy fairs is have the companies in this wacky world of ours learned anything. Have they figured out that success in diabetes is not related to patient outcomes? Have they figured out that it’s not about the toys in the toy chest?
Interestingly it’s the drug companies who have learned the most. That as much as they would like it to be about who has the best therapy options win. They have resigned themselves to the fact that it’s the payor who controls their destiny. That . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.